Abdoulaye Sissoko, Ibrahima Teguete, Mohamed Yaya Djire, Moussa Arouna Bagayoko, Boulaye Diawara, Amose Kodio, Siaka Diarra, Fatoumata Matokoma Sidibe, Madani Ly, Sidy Traore, Oumar Sangho, Pierre A Togo, Moussa A Ouattara, Drissa Traore, Sara Sissoko
{"title":"[巴马科母婴 \"卢森堡 \"女子教学医院的乳腺癌存活率]。","authors":"Abdoulaye Sissoko, Ibrahima Teguete, Mohamed Yaya Djire, Moussa Arouna Bagayoko, Boulaye Diawara, Amose Kodio, Siaka Diarra, Fatoumata Matokoma Sidibe, Madani Ly, Sidy Traore, Oumar Sangho, Pierre A Togo, Moussa A Ouattara, Drissa Traore, Sara Sissoko","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer is one of the main causes of morbidity and mortality in Africa and Mali and its prognosis remains serious with very low survival. We initiated this study to determine the overall and specific survival rate by treatment type.</p><p><strong>Patients and methods: </strong>This was a cross-sectional study from January 1, 2016 to October 31, 2021. It concerned all women who had been seen in the obstetric gynecology department of the teaching hospital Luxembourg in Bamako during the study period. We conducted a multivariate analysis of the factors influencing survival after logistic regression according to the Cox model.</p><p><strong>Results: </strong>We recorded 70 cases of breast cancer among 41613 gynecological consultations or 0.16%. Over the months there is a very rapid decrease in survival. The chemotherapy improves survival, surgery and radiotherapy greatly contribute to the improvement. Concerning hormone therapy, it protects subjects with a statistically significant probability (P<0,05).</p><p><strong>Conclusion: </strong>Breast cancer survival remains very low in the department, the need for well-organized screening campaigns and early and multidisciplinary case management.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"44-49"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Breast Cancer Survival In Women Teaching Hospital Mother And Child «Luxembourg» Bamako].\",\"authors\":\"Abdoulaye Sissoko, Ibrahima Teguete, Mohamed Yaya Djire, Moussa Arouna Bagayoko, Boulaye Diawara, Amose Kodio, Siaka Diarra, Fatoumata Matokoma Sidibe, Madani Ly, Sidy Traore, Oumar Sangho, Pierre A Togo, Moussa A Ouattara, Drissa Traore, Sara Sissoko\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Breast cancer is one of the main causes of morbidity and mortality in Africa and Mali and its prognosis remains serious with very low survival. We initiated this study to determine the overall and specific survival rate by treatment type.</p><p><strong>Patients and methods: </strong>This was a cross-sectional study from January 1, 2016 to October 31, 2021. It concerned all women who had been seen in the obstetric gynecology department of the teaching hospital Luxembourg in Bamako during the study period. We conducted a multivariate analysis of the factors influencing survival after logistic regression according to the Cox model.</p><p><strong>Results: </strong>We recorded 70 cases of breast cancer among 41613 gynecological consultations or 0.16%. Over the months there is a very rapid decrease in survival. The chemotherapy improves survival, surgery and radiotherapy greatly contribute to the improvement. Concerning hormone therapy, it protects subjects with a statistically significant probability (P<0,05).</p><p><strong>Conclusion: </strong>Breast cancer survival remains very low in the department, the need for well-organized screening campaigns and early and multidisciplinary case management.</p>\",\"PeriodicalId\":74061,\"journal\":{\"name\":\"Le Mali medical\",\"volume\":\"39 2\",\"pages\":\"44-49\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Le Mali medical\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Mali medical","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Breast Cancer Survival In Women Teaching Hospital Mother And Child «Luxembourg» Bamako].
Introduction: Breast cancer is one of the main causes of morbidity and mortality in Africa and Mali and its prognosis remains serious with very low survival. We initiated this study to determine the overall and specific survival rate by treatment type.
Patients and methods: This was a cross-sectional study from January 1, 2016 to October 31, 2021. It concerned all women who had been seen in the obstetric gynecology department of the teaching hospital Luxembourg in Bamako during the study period. We conducted a multivariate analysis of the factors influencing survival after logistic regression according to the Cox model.
Results: We recorded 70 cases of breast cancer among 41613 gynecological consultations or 0.16%. Over the months there is a very rapid decrease in survival. The chemotherapy improves survival, surgery and radiotherapy greatly contribute to the improvement. Concerning hormone therapy, it protects subjects with a statistically significant probability (P<0,05).
Conclusion: Breast cancer survival remains very low in the department, the need for well-organized screening campaigns and early and multidisciplinary case management.